CLINICAL PHASE II RESULTS OF PMZ-2010 (CENTHAQUIN) AS A RESUSCITATIVE AGENT FOR HYPOVOLEMIC SHOCK

被引：0

作者：

Gulati, Anil

Jain, Dinesh ^{[1
]}

Agrawal, Nilesh ^{[2
]}

Rahate, Prashant ^{[3
]}

Das, Soumen ^{[4
]}

Chowdhuri, Rajat ^{[4
]}

Dhibar, Deba ^{[5
]}

Prabhu, Madhav ^{[6
]}

Haveri, Sameer ^{[6
]}

Agarwal, Rohit ^{[7
]}

Lavhale, Manish ^{[8
]}

机构：

[1] Dayanand Med Coll, Ludhiana, Punjab, India

[2] New Era Hosp, Nagpur, Maharashtra, India

[3] Seven Star Hosp, Nagpur, Maharashtra, India

[4] Inst Post Grad Med Educ & Res, Kolkata, India

[5] Post Grad Inst Med Educ & Res, Chandigarh, India

[6] KLEs Dr Prabhakar Kore Hosp & Med Res Ctr, Belgaum, India

[7] Oriana Hosp, Varanasi, Uttar Pradesh, India

[8] Pharmazz India Private Ltd, Greater Noida, India

来源：

CRITICAL CARE MEDICINE | 2019年 / 47卷

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页数：1

共 50 条

[11] Irinotecan as single agent in the treatment of colorectal cancer: results of phase II studies
Van Cutsem, E
Peeters, M
BULLETIN DU CANCER, 1998, : 33 - 37
[12] Results published on Phase II clinical trial for dengue vaccine
O'Hare, Alice
EXPERT REVIEW OF VACCINES, 2012, 11 (11) : 1287 - 1287
[13] HCV protease inhibitor telaprevir: phase II clinical results
Peese, Kevin
DRUG DISCOVERY TODAY, 2010, 15 (9-10) : 406 - 406
[14] ONYX-015 phase II clinical trial results
Senior, Kathryn
LANCET ONCOLOGY, 2001, 2 (01): : 3 - 3
[15] Novel anxiolytic Selank: results of the phase II clinical trials
Neznamov, GG
Teleshova, ES
Bochkarev, VK
Koschelev, VV
Syunyakov, TS
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S159 - S160
[16] Er:YAG clinical results on hard tissue:: Phase II
Cozean, CD
Powell, L
LASERS IN DENTISTRY IV, PROCEEDINGS OF, 1998, 3248 : 33 - 39
[17] Quetiapine: Results of four phase II and III clinical trials
King, DJ
EUROPEAN PSYCHIATRY, 1998, 13 : 15S - 21S
[18] A Bayesian phase I/II design for cancer clinical trials combining an immunotherapeutic agent with a chemotherapeutic agent
Guo, Beibei
Garrett-Mayer, Elizabeth
Liu, Suyu
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS, 2021, 70 (05) : 1210 - 1229
[19] OLANZAPINE - A POTENTIAL ATYPICAL ANTIPSYCHOTIC AGENT - PHASE-II CLINICAL FINDINGS
HARRISON, DA
SATTERLEE, W
TRAN, P
BEASLEY, CM
TOLLEFSON, GD
SCHIZOPHRENIA RESEARCH, 1994, 11 (02) : 107 - 107
[20] Istaroxime - A novel lusitropic and inotropic agent: Results of a phase I-II study
Ghali, J
Smith, W
Torre-Amione, G
Haynos, W
Rayburn, B
Amato, A
Zhang, D
Cowart, D
Valentini, G
Carminati, P
Gheorghiade, M
JOURNAL OF CARDIAC FAILURE, 2005, 11 (06) : S152 - S152

← 1 2 3 4 5 →